Global Burosumab Market Research Report 2025(Status and Outlook)
Burosumab , a fully human IgG1 monoclonal antibody directed at fibroblast growth factor 23 (FGF23), is indicated for the treatment of X-linked hypophosphatemia (XLH), a condition associated with excessive FGF23 production.
This report offers a comprehensive and in-depth analysis of the global Burosumab market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Burosumab market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Burosumab market.
Global Burosumab Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ultragenyx
Kyowa Kirin
Market Segmentation (by Type)
10mg/mL
20mg/mL
30mg/mL
Market Segmentation (by Application)
Minor Patients Over 1 Year Old
Adult Patients
Geographic Segmentation
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burosumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Burosumab, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
This report offers a comprehensive and in-depth analysis of the global Burosumab market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Burosumab market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Burosumab market.
Global Burosumab Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
Ultragenyx
Kyowa Kirin
Market Segmentation (by Type)
10mg/mL
20mg/mL
30mg/mL
Market Segmentation (by Application)
Minor Patients Over 1 Year Old
Adult Patients
Geographic Segmentation
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
- South America (Brazil, Argentina, Columbia, Rest of South America)
- The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
- Industry drivers, restraints, and opportunities covered in the study
- Neutral perspective on the market performance
- Recent industry trends and developments
- Competitive landscape & strategies of key players
- Potential & niche segments and regions exhibiting promising growth covered
- Historical, current, and projected market size, in terms of value
- In-depth analysis of the Burosumab Market
- Overview of the regional outlook of the Burosumab Market:
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Burosumab Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Burosumab, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
- Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
- This enables you to anticipate market changes to remain ahead of your competitors
- You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
- The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
- Provision of market value data for each segment and sub-segment
- Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
- Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
- Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
- Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
- The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
- Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
- Provides insight into the market through Value Chain
- Market dynamics scenario, along with growth opportunities of the market in the years to come
- 6-month post-sales analyst support
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Burosumab
1.2 Key Market Segments
1.2.1 Burosumab Segment by Type
1.2.2 Burosumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BUROSUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burosumab Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Burosumab Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BUROSUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Burosumab Product Life Cycle
3.3 Global Burosumab Sales by Manufacturers (2020-2025)
3.4 Global Burosumab Revenue Market Share by Manufacturers (2020-2025)
3.5 Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Burosumab Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Burosumab Market Competitive Situation and Trends
3.8.1 Burosumab Market Concentration Rate
3.8.2 Global 5 and 10 Largest Burosumab Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BUROSUMAB INDUSTRY CHAIN ANALYSIS
4.1 Burosumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BUROSUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Burosumab Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Burosumab Market
5.7 ESG Ratings of Leading Companies
6 BUROSUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burosumab Sales Market Share by Type (2020-2025)
6.3 Global Burosumab Market Size Market Share by Type (2020-2025)
6.4 Global Burosumab Price by Type (2020-2025)
7 BUROSUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burosumab Market Sales by Application (2020-2025)
7.3 Global Burosumab Market Size (M USD) by Application (2020-2025)
7.4 Global Burosumab Sales Growth Rate by Application (2020-2025)
8 BUROSUMAB MARKET SALES BY REGION
8.1 Global Burosumab Sales by Region
8.1.1 Global Burosumab Sales by Region
8.1.2 Global Burosumab Sales Market Share by Region
8.2 Global Burosumab Market Size by Region
8.2.1 Global Burosumab Market Size by Region
8.2.2 Global Burosumab Market Size Market Share by Region
8.3 North America
8.3.1 North America Burosumab Sales by Country
8.3.2 North America Burosumab Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Burosumab Sales by Country
8.4.2 Europe Burosumab Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Burosumab Sales by Region
8.5.2 Asia Pacific Burosumab Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Burosumab Sales by Country
8.6.2 South America Burosumab Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Burosumab Sales by Region
8.7.2 Middle East and Africa Burosumab Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BUROSUMAB MARKET PRODUCTION BY REGION
9.1 Global Production of Burosumab by Region(2020-2025)
9.2 Global Burosumab Revenue Market Share by Region (2020-2025)
9.3 Global Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Burosumab Production
9.4.1 North America Burosumab Production Growth Rate (2020-2025)
9.4.2 North America Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Burosumab Production
9.5.1 Europe Burosumab Production Growth Rate (2020-2025)
9.5.2 Europe Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Burosumab Production (2020-2025)
9.6.1 Japan Burosumab Production Growth Rate (2020-2025)
9.6.2 Japan Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Burosumab Production (2020-2025)
9.7.1 China Burosumab Production Growth Rate (2020-2025)
9.7.2 China Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ultragenyx
10.1.1 Ultragenyx Basic Information
10.1.2 Ultragenyx Burosumab Product Overview
10.1.3 Ultragenyx Burosumab Product Market Performance
10.1.4 Ultragenyx Business Overview
10.1.5 Ultragenyx SWOT Analysis
10.1.6 Ultragenyx Recent Developments
10.2 Kyowa Kirin
10.2.1 Kyowa Kirin Basic Information
10.2.2 Kyowa Kirin Burosumab Product Overview
10.2.3 Kyowa Kirin Burosumab Product Market Performance
10.2.4 Kyowa Kirin Business Overview
10.2.5 Kyowa Kirin SWOT Analysis
10.2.6 Kyowa Kirin Recent Developments
11 BUROSUMAB MARKET FORECAST BY REGION
11.1 Global Burosumab Market Size Forecast
11.2 Global Burosumab Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Burosumab Market Size Forecast by Country
11.2.3 Asia Pacific Burosumab Market Size Forecast by Region
11.2.4 South America Burosumab Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Burosumab by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Burosumab Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Burosumab by Type (2026-2033)
12.1.2 Global Burosumab Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Burosumab by Type (2026-2033)
12.2 Global Burosumab Market Forecast by Application (2026-2033)
12.2.1 Global Burosumab Sales (K MT) Forecast by Application
12.2.2 Global Burosumab Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Burosumab
1.2 Key Market Segments
1.2.1 Burosumab Segment by Type
1.2.2 Burosumab Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 BUROSUMAB MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Burosumab Market Size (M USD) Estimates and Forecasts (2020-2033)
2.1.2 Global Burosumab Sales Estimates and Forecasts (2020-2033)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 BUROSUMAB MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Burosumab Product Life Cycle
3.3 Global Burosumab Sales by Manufacturers (2020-2025)
3.4 Global Burosumab Revenue Market Share by Manufacturers (2020-2025)
3.5 Burosumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Burosumab Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Burosumab Market Competitive Situation and Trends
3.8.1 Burosumab Market Concentration Rate
3.8.2 Global 5 and 10 Largest Burosumab Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 BUROSUMAB INDUSTRY CHAIN ANALYSIS
4.1 Burosumab Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF BUROSUMAB MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Burosumab Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Burosumab Market
5.7 ESG Ratings of Leading Companies
6 BUROSUMAB MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Burosumab Sales Market Share by Type (2020-2025)
6.3 Global Burosumab Market Size Market Share by Type (2020-2025)
6.4 Global Burosumab Price by Type (2020-2025)
7 BUROSUMAB MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Burosumab Market Sales by Application (2020-2025)
7.3 Global Burosumab Market Size (M USD) by Application (2020-2025)
7.4 Global Burosumab Sales Growth Rate by Application (2020-2025)
8 BUROSUMAB MARKET SALES BY REGION
8.1 Global Burosumab Sales by Region
8.1.1 Global Burosumab Sales by Region
8.1.2 Global Burosumab Sales Market Share by Region
8.2 Global Burosumab Market Size by Region
8.2.1 Global Burosumab Market Size by Region
8.2.2 Global Burosumab Market Size Market Share by Region
8.3 North America
8.3.1 North America Burosumab Sales by Country
8.3.2 North America Burosumab Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Burosumab Sales by Country
8.4.2 Europe Burosumab Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Burosumab Sales by Region
8.5.2 Asia Pacific Burosumab Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Burosumab Sales by Country
8.6.2 South America Burosumab Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Burosumab Sales by Region
8.7.2 Middle East and Africa Burosumab Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 BUROSUMAB MARKET PRODUCTION BY REGION
9.1 Global Production of Burosumab by Region(2020-2025)
9.2 Global Burosumab Revenue Market Share by Region (2020-2025)
9.3 Global Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Burosumab Production
9.4.1 North America Burosumab Production Growth Rate (2020-2025)
9.4.2 North America Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Burosumab Production
9.5.1 Europe Burosumab Production Growth Rate (2020-2025)
9.5.2 Europe Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Burosumab Production (2020-2025)
9.6.1 Japan Burosumab Production Growth Rate (2020-2025)
9.6.2 Japan Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Burosumab Production (2020-2025)
9.7.1 China Burosumab Production Growth Rate (2020-2025)
9.7.2 China Burosumab Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 Ultragenyx
10.1.1 Ultragenyx Basic Information
10.1.2 Ultragenyx Burosumab Product Overview
10.1.3 Ultragenyx Burosumab Product Market Performance
10.1.4 Ultragenyx Business Overview
10.1.5 Ultragenyx SWOT Analysis
10.1.6 Ultragenyx Recent Developments
10.2 Kyowa Kirin
10.2.1 Kyowa Kirin Basic Information
10.2.2 Kyowa Kirin Burosumab Product Overview
10.2.3 Kyowa Kirin Burosumab Product Market Performance
10.2.4 Kyowa Kirin Business Overview
10.2.5 Kyowa Kirin SWOT Analysis
10.2.6 Kyowa Kirin Recent Developments
11 BUROSUMAB MARKET FORECAST BY REGION
11.1 Global Burosumab Market Size Forecast
11.2 Global Burosumab Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Burosumab Market Size Forecast by Country
11.2.3 Asia Pacific Burosumab Market Size Forecast by Region
11.2.4 South America Burosumab Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Burosumab by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2033)
12.1 Global Burosumab Market Forecast by Type (2026-2033)
12.1.1 Global Forecasted Sales of Burosumab by Type (2026-2033)
12.1.2 Global Burosumab Market Size Forecast by Type (2026-2033)
12.1.3 Global Forecasted Price of Burosumab by Type (2026-2033)
12.2 Global Burosumab Market Forecast by Application (2026-2033)
12.2.1 Global Burosumab Sales (K MT) Forecast by Application
12.2.2 Global Burosumab Market Size (M USD) Forecast by Application (2026-2033)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Burosumab Market Size Comparison by Region (M USD)
Table 5. Global Burosumab Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Burosumab Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Burosumab Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Burosumab Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2024)
Table 10. Global Market Burosumab Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Burosumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Burosumab Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Burosumab Sales by Type (K MT)
Table 26. Global Burosumab Market Size by Type (M USD)
Table 27. Global Burosumab Sales (K MT) by Type (2020-2025)
Table 28. Global Burosumab Sales Market Share by Type (2020-2025)
Table 29. Global Burosumab Market Size (M USD) by Type (2020-2025)
Table 30. Global Burosumab Market Size Share by Type (2020-2025)
Table 31. Global Burosumab Price (USD/KG) by Type (2020-2025)
Table 32. Global Burosumab Sales (K MT) by Application
Table 33. Global Burosumab Market Size by Application
Table 34. Global Burosumab Sales by Application (2020-2025) & (K MT)
Table 35. Global Burosumab Sales Market Share by Application (2020-2025)
Table 36. Global Burosumab Market Size by Application (2020-2025) & (M USD)
Table 37. Global Burosumab Market Share by Application (2020-2025)
Table 38. Global Burosumab Sales Growth Rate by Application (2020-2025)
Table 39. Global Burosumab Sales by Region (2020-2025) & (K MT)
Table 40. Global Burosumab Sales Market Share by Region (2020-2025)
Table 41. Global Burosumab Market Size by Region (2020-2025) & (M USD)
Table 42. Global Burosumab Market Size Market Share by Region (2020-2025)
Table 43. North America Burosumab Sales by Country (2020-2025) & (K MT)
Table 44. North America Burosumab Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Burosumab Sales by Country (2020-2025) & (K MT)
Table 46. Europe Burosumab Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Burosumab Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Burosumab Market Size by Region (2020-2025) & (M USD)
Table 49. South America Burosumab Sales by Country (2020-2025) & (K MT)
Table 50. South America Burosumab Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Burosumab Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Burosumab Market Size by Region (2020-2025) & (M USD)
Table 53. Global Burosumab Production (K MT) by Region(2020-2025)
Table 54. Global Burosumab Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Burosumab Revenue Market Share by Region (2020-2025)
Table 56. Global Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Ultragenyx Basic Information
Table 62. Ultragenyx Burosumab Product Overview
Table 63. Ultragenyx Burosumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Ultragenyx Business Overview
Table 65. Ultragenyx SWOT Analysis
Table 66. Ultragenyx Recent Developments
Table 67. Kyowa Kirin Basic Information
Table 68. Kyowa Kirin Burosumab Product Overview
Table 69. Kyowa Kirin Burosumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Kyowa Kirin Business Overview
Table 71. Kyowa Kirin SWOT Analysis
Table 72. Kyowa Kirin Recent Developments
Table 73. Global Burosumab Sales Forecast by Region (2026-2033) & (K MT)
Table 74. Global Burosumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 75. North America Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 76. North America Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 77. Europe Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 78. Europe Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 79. Asia Pacific Burosumab Sales Forecast by Region (2026-2033) & (K MT)
Table 80. Asia Pacific Burosumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 81. South America Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 82. South America Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 83. Middle East and Africa Burosumab Sales Forecast by Country (2026-2033) & (Units)
Table 84. Middle East and Africa Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 85. Global Burosumab Sales Forecast by Type (2026-2033) & (K MT)
Table 86. Global Burosumab Market Size Forecast by Type (2026-2033) & (M USD)
Table 87. Global Burosumab Price Forecast by Type (2026-2033) & (USD/KG)
Table 88. Global Burosumab Sales (K MT) Forecast by Application (2026-2033)
Table 89. Global Burosumab Market Size Forecast by Application (2026-2033) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Market Size (M USD) Segment Executive Summary
Table 4. Burosumab Market Size Comparison by Region (M USD)
Table 5. Global Burosumab Sales (K MT) by Manufacturers (2020-2025)
Table 6. Global Burosumab Sales Market Share by Manufacturers (2020-2025)
Table 7. Global Burosumab Revenue (M USD) by Manufacturers (2020-2025)
Table 8. Global Burosumab Revenue Share by Manufacturers (2020-2025)
Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Burosumab as of 2024)
Table 10. Global Market Burosumab Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 11. Manufacturers? Manufacturing Sites, Areas Served
Table 12. Manufacturers? Product Type
Table 13. Global Burosumab Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Mergers & Acquisitions, Expansion Plans
Table 15. Market Overview of Key Raw Materials
Table 16. Midstream Market Analysis
Table 17. Downstream Customer Analysis
Table 18. Key Development Trends
Table 19. Driving Factors
Table 20. Burosumab Market Challenges
Table 21. Goldman Sachs' forecast real GDP growth rate for 2024-2026
Table 22. S&P Global ' Forecast Real GDP Growth Rate For 2024-2027
Table 23. World Bank ' Forecast Real GDP Growth Rate For 2024-2026
Table 24. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 25. Global Burosumab Sales by Type (K MT)
Table 26. Global Burosumab Market Size by Type (M USD)
Table 27. Global Burosumab Sales (K MT) by Type (2020-2025)
Table 28. Global Burosumab Sales Market Share by Type (2020-2025)
Table 29. Global Burosumab Market Size (M USD) by Type (2020-2025)
Table 30. Global Burosumab Market Size Share by Type (2020-2025)
Table 31. Global Burosumab Price (USD/KG) by Type (2020-2025)
Table 32. Global Burosumab Sales (K MT) by Application
Table 33. Global Burosumab Market Size by Application
Table 34. Global Burosumab Sales by Application (2020-2025) & (K MT)
Table 35. Global Burosumab Sales Market Share by Application (2020-2025)
Table 36. Global Burosumab Market Size by Application (2020-2025) & (M USD)
Table 37. Global Burosumab Market Share by Application (2020-2025)
Table 38. Global Burosumab Sales Growth Rate by Application (2020-2025)
Table 39. Global Burosumab Sales by Region (2020-2025) & (K MT)
Table 40. Global Burosumab Sales Market Share by Region (2020-2025)
Table 41. Global Burosumab Market Size by Region (2020-2025) & (M USD)
Table 42. Global Burosumab Market Size Market Share by Region (2020-2025)
Table 43. North America Burosumab Sales by Country (2020-2025) & (K MT)
Table 44. North America Burosumab Market Size by Country (2020-2025) & (M USD)
Table 45. Europe Burosumab Sales by Country (2020-2025) & (K MT)
Table 46. Europe Burosumab Market Size by Country (2020-2025) & (M USD)
Table 47. Asia Pacific Burosumab Sales by Region (2020-2025) & (K MT)
Table 48. Asia Pacific Burosumab Market Size by Region (2020-2025) & (M USD)
Table 49. South America Burosumab Sales by Country (2020-2025) & (K MT)
Table 50. South America Burosumab Market Size by Country (2020-2025) & (M USD)
Table 51. Middle East and Africa Burosumab Sales by Region (2020-2025) & (K MT)
Table 52. Middle East and Africa Burosumab Market Size by Region (2020-2025) & (M USD)
Table 53. Global Burosumab Production (K MT) by Region(2020-2025)
Table 54. Global Burosumab Revenue (US$ Million) by Region (2020-2025)
Table 55. Global Burosumab Revenue Market Share by Region (2020-2025)
Table 56. Global Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 57. North America Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. Europe Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Japan Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. China Burosumab Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Ultragenyx Basic Information
Table 62. Ultragenyx Burosumab Product Overview
Table 63. Ultragenyx Burosumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. Ultragenyx Business Overview
Table 65. Ultragenyx SWOT Analysis
Table 66. Ultragenyx Recent Developments
Table 67. Kyowa Kirin Basic Information
Table 68. Kyowa Kirin Burosumab Product Overview
Table 69. Kyowa Kirin Burosumab Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 70. Kyowa Kirin Business Overview
Table 71. Kyowa Kirin SWOT Analysis
Table 72. Kyowa Kirin Recent Developments
Table 73. Global Burosumab Sales Forecast by Region (2026-2033) & (K MT)
Table 74. Global Burosumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 75. North America Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 76. North America Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 77. Europe Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 78. Europe Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 79. Asia Pacific Burosumab Sales Forecast by Region (2026-2033) & (K MT)
Table 80. Asia Pacific Burosumab Market Size Forecast by Region (2026-2033) & (M USD)
Table 81. South America Burosumab Sales Forecast by Country (2026-2033) & (K MT)
Table 82. South America Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 83. Middle East and Africa Burosumab Sales Forecast by Country (2026-2033) & (Units)
Table 84. Middle East and Africa Burosumab Market Size Forecast by Country (2026-2033) & (M USD)
Table 85. Global Burosumab Sales Forecast by Type (2026-2033) & (K MT)
Table 86. Global Burosumab Market Size Forecast by Type (2026-2033) & (M USD)
Table 87. Global Burosumab Price Forecast by Type (2026-2033) & (USD/KG)
Table 88. Global Burosumab Sales (K MT) Forecast by Application (2026-2033)
Table 89. Global Burosumab Market Size Forecast by Application (2026-2033) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Burosumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burosumab Market Size (M USD), 2024-2033
Figure 5. Global Burosumab Market Size (M USD) (2020-2033)
Figure 6. Global Burosumab Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burosumab Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Burosumab Product Life Cycle
Figure 13. Burosumab Sales Share by Manufacturers in 2024
Figure 14. Global Burosumab Revenue Share by Manufacturers in 2024
Figure 15. Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Burosumab Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Burosumab Revenue in 2024
Figure 18. Industry Chain Map of Burosumab
Figure 19. Global Burosumab Market PEST Analysis
Figure 20. Global Burosumab Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Burosumab Market Share by Type
Figure 27. Sales Market Share of Burosumab by Type (2020-2025)
Figure 28. Sales Market Share of Burosumab by Type in 2024
Figure 29. Market Size Share of Burosumab by Type (2020-2025)
Figure 30. Market Size Share of Burosumab by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Burosumab Market Share by Application
Figure 33. Global Burosumab Sales Market Share by Application (2020-2025)
Figure 34. Global Burosumab Sales Market Share by Application in 2024
Figure 35. Global Burosumab Market Share by Application (2020-2025)
Figure 36. Global Burosumab Market Share by Application in 2024
Figure 37. Global Burosumab Sales Growth Rate by Application (2020-2025)
Figure 38. Global Burosumab Sales Market Share by Region (2020-2025)
Figure 39. Global Burosumab Market Size Market Share by Region (2020-2025)
Figure 40. North America Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Burosumab Sales Market Share by Country in 2024
Figure 43. North America Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Burosumab Market Size Market Share by Country in 2024
Figure 45. U.S. Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Burosumab Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Burosumab Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Burosumab Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Burosumab Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Burosumab Sales Market Share by Country in 2024
Figure 53. Europe Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Burosumab Market Size Market Share by Country in 2024
Figure 55. Germany Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Burosumab Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Burosumab Sales Market Share by Region in 2024
Figure 67. Asia Pacific Burosumab Market Size Market Share by Region in 2024
Figure 68. China Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Burosumab Sales and Growth Rate (K MT)
Figure 79. South America Burosumab Sales Market Share by Country in 2024
Figure 80. South America Burosumab Market Size and Growth Rate (M USD)
Figure 81. South America Burosumab Market Size Market Share by Country in 2024
Figure 82. Brazil Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Burosumab Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Burosumab Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Burosumab Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Burosumab Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Burosumab Production Market Share by Region (2020-2025)
Figure 103. North America Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 106. China Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Burosumab Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Burosumab Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Burosumab Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Burosumab Market Share Forecast by Type (2026-2033)
Figure 111. Global Burosumab Sales Forecast by Application (2026-2033)
Figure 112. Global Burosumab Market Share Forecast by Application (2026-2033)
Figure 1. Product Picture of Burosumab
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Burosumab Market Size (M USD), 2024-2033
Figure 5. Global Burosumab Market Size (M USD) (2020-2033)
Figure 6. Global Burosumab Sales (K MT) & (2020-2033)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Burosumab Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Burosumab Product Life Cycle
Figure 13. Burosumab Sales Share by Manufacturers in 2024
Figure 14. Global Burosumab Revenue Share by Manufacturers in 2024
Figure 15. Burosumab Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024
Figure 16. Global Market Burosumab Average Price (USD/KG) of Key Manufacturers in 2024
Figure 17. The Global 5 and 10 Largest Players: Market Share by Burosumab Revenue in 2024
Figure 18. Industry Chain Map of Burosumab
Figure 19. Global Burosumab Market PEST Analysis
Figure 20. Global Burosumab Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Burosumab Market Share by Type
Figure 27. Sales Market Share of Burosumab by Type (2020-2025)
Figure 28. Sales Market Share of Burosumab by Type in 2024
Figure 29. Market Size Share of Burosumab by Type (2020-2025)
Figure 30. Market Size Share of Burosumab by Type in 2024
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Burosumab Market Share by Application
Figure 33. Global Burosumab Sales Market Share by Application (2020-2025)
Figure 34. Global Burosumab Sales Market Share by Application in 2024
Figure 35. Global Burosumab Market Share by Application (2020-2025)
Figure 36. Global Burosumab Market Share by Application in 2024
Figure 37. Global Burosumab Sales Growth Rate by Application (2020-2025)
Figure 38. Global Burosumab Sales Market Share by Region (2020-2025)
Figure 39. Global Burosumab Market Size Market Share by Region (2020-2025)
Figure 40. North America Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Burosumab Sales Market Share by Country in 2024
Figure 43. North America Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Burosumab Market Size Market Share by Country in 2024
Figure 45. U.S. Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Burosumab Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Burosumab Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Burosumab Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Burosumab Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Burosumab Sales Market Share by Country in 2024
Figure 53. Europe Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Burosumab Market Size Market Share by Country in 2024
Figure 55. Germany Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Burosumab Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Burosumab Sales Market Share by Region in 2024
Figure 67. Asia Pacific Burosumab Market Size Market Share by Region in 2024
Figure 68. China Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Burosumab Sales and Growth Rate (K MT)
Figure 79. South America Burosumab Sales Market Share by Country in 2024
Figure 80. South America Burosumab Market Size and Growth Rate (M USD)
Figure 81. South America Burosumab Market Size Market Share by Country in 2024
Figure 82. Brazil Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Burosumab Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Burosumab Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Burosumab Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Burosumab Market Size Market Share by Region in 2024
Figure 92. Saudi Arabia Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Burosumab Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Burosumab Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Burosumab Production Market Share by Region (2020-2025)
Figure 103. North America Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 106. China Burosumab Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Burosumab Sales Forecast by Volume (2020-2033) & (K MT)
Figure 108. Global Burosumab Market Size Forecast by Value (2020-2033) & (M USD)
Figure 109. Global Burosumab Sales Market Share Forecast by Type (2026-2033)
Figure 110. Global Burosumab Market Share Forecast by Type (2026-2033)
Figure 111. Global Burosumab Sales Forecast by Application (2026-2033)
Figure 112. Global Burosumab Market Share Forecast by Application (2026-2033)
